Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 425 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Treatment of Zollinger-Ellison Syndrome With Prevacid				Phase IV				F030107005 NCT00204373
	Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy				Phase IV				04-08-09-04 NCT00245518
	Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation				Phase IV				hsc 031192 ind 70268, NCT00285272
	Evaluating the Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment				Phase IV				R01 MH071580 DATR A3-NSS, NCT00352885
	A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer				Phase IV				A0081128 NCT00381095
	Pregabalin in Preventing and Treating Peripheral Neuropathy Caused by Chemotherapy in Patients Undergoing Chemotherapy for Advanced Colorectal Cancer				Phase IV				PFIZER-A0081124 RAH-060919, NCT00380874
	Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients				Phase IV				RASALL NCT00186940
	Effect of Eszopiclone on Sleep Disturbance & Pain in Cancer				Phase IV				UCSD 060340 ESRC 054, NCT00365261
	Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy				Phase IV				PRO06080002 (REBBeCA II) NCT00485953
	Intermittent Use of Aerosolized Ribavirin for Treatment of RSV				Phase IV				ID03-0010 NCT00500578


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute